ArticleOncoTargets and therapy2021

Estimating Survival in Patients with Non-Small-Cell Lung Cancer and Brain Metastases: A Verification of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA).

Ji Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.